These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3104275)

  • 1. Imipenem and ceftazidime resistance in Pseudomonas aeruginosa and Klebsiella pneumoniae.
    Knothe H; Antal M; Krcméry V
    J Antimicrob Chemother; 1987 Jan; 19(1):136-8. PubMed ID: 3104275
    [No Abstract]   [Full Text] [Related]  

  • 2. High prevalence of ceftazidime-resistant Klebsiella pneumoniae and increase of imipenem-resistant Pseudomonas aeruginosa and Acinetobacter spp. in Korea: a KONSAR program in 2004.
    Lee K; Lim CH; Cho JH; Lee WG; Uh Y; Kim HJ; Yong D; Chong Y;
    Yonsei Med J; 2006 Oct; 47(5):634-45. PubMed ID: 17066507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antibacterial effect of N-formimidoyl-thienamycin in combination with amikacin, cefoxitin and fosfomycin on K. pneumoniae and P. aeruginosa].
    Schröter G; Schrettenbrunner A
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Dec; 253(3):355-7. PubMed ID: 6820589
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro activity of ceftazidime, cefepime and imipenem on 1,005 Pseudomonas aeruginosa clinical isolates either susceptible or resistant to beta-lactams.
    Bonfiglio G; Marchetti F
    Chemotherapy; 2000; 46(4):229-34. PubMed ID: 10859428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of ceftazidime and N-formimidoyl thienamycin against gentamicin-susceptible and resistant Pseudomonas aeruginosa.
    Alford RH
    J Antimicrob Chemother; 1983 Jun; 11(6):599-601. PubMed ID: 6411675
    [No Abstract]   [Full Text] [Related]  

  • 6. Postantibiotic effect of imipenem on Pseudomonas aeruginosa.
    Bustamante CI; Drusano GL; Tatem BA; Standiford HC
    Antimicrob Agents Chemother; 1984 Nov; 26(5):678-82. PubMed ID: 6440477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial activity of ceftazidime-avibactam and comparator agents when tested against bacterial isolates causing infection in cancer patients (2013-2014).
    Sader HS; Castanheira M; Jones RN; Flamm RK
    Diagn Microbiol Infect Dis; 2017 Mar; 87(3):261-265. PubMed ID: 28069328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postantibiotic effect of carbapenems against Pseudomonas aeruginosa.
    Hikida M; Yamazaki Y; Yoshida M; Kawashima K; Nishiki K; Mitsuhashi S
    J Antibiot (Tokyo); 1995 Aug; 48(8):891-2. PubMed ID: 7592037
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro interaction of ceftazidime-avibactam in combination with different antimicrobials against KPC-producing Klebsiella pneumoniae clinical isolates.
    Gaibani P; Lewis RE; Volpe SL; Giannella M; Campoli C; Landini MP; Viale P; Re MC; Ambretti S
    Int J Infect Dis; 2017 Dec; 65():1-3. PubMed ID: 28951106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of in vitro selected resistance of Pseudomonas aeruginosa to cefoperazone, ceftazidime, azthreonam and imipenem.
    Van der Auwera P; Husson M; Bulliard G
    Drugs Exp Clin Res; 1986; 12(11):871-83. PubMed ID: 3102194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bactericidal activity of biapenem against various efflux system mutants of Pseudomonas aeruginosa].
    Hiraishi T; Miyata A; Takata T; Araake M; Ogawa H; Gotoh N; Nishino T
    Jpn J Antibiot; 2002 Feb; 55(1):67-76. PubMed ID: 11977922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of sulperazon against recent isolates of ceftazidime-resistant bacteria.
    Lim VK; Halijah MY
    Med J Malaysia; 2001 Sep; 56(3):365-9. PubMed ID: 11732084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum bactericidal activity and killing rate for volunteers receiving imipenem, imipenem plus amikacin, and ceftazidime plus amikacin against Pseudomonas aeruginosa.
    Van der Auwera P; Klastersky J; Lagast H; Husson M
    Antimicrob Agents Chemother; 1986 Jul; 30(1):122-6. PubMed ID: 3092729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro studies of antibiotic combinations with special emphasis on the evaluation of newly developed methods.
    Zinner SH; Blaser J
    J Antimicrob Chemother; 1986 Mar; 17 Suppl A():1-5. PubMed ID: 3086275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum bactericidal activity of mezlocillin, ceftazidime, mezlocillin/ceftazidime and mezlocillin/amikacin against Klebsiella pneumoniae and Pseudomonas aeruginosa.
    Van Laethem Y; Klastersky J
    Eur J Clin Microbiol; 1986 Feb; 5(1):110-4. PubMed ID: 3084239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further studies of transferable antibiotic resistance in strains of Pseudomonas aeruginosa from four clinical settings in three countries.
    Blahová J; Hupková-Lesická M; Králiková K; Krcméry V; Kubonová K; Torsová V; Bartoníková N; Schäfer V
    J Chemother; 1998 Jun; 10(3):215-20. PubMed ID: 9669646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antimicrobial susceptibility of Pseudomonas aeruginosa isolated at Kochi Municipal Central Hospital in the last 3 years].
    Nasu Y; Abe M; Ono N; Araki M; Horimi T; Takahashi I
    Jpn J Antibiot; 2004 Oct; 57(5):438-48. PubMed ID: 15655905
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Shields RK; Nguyen MH; Press EG; Chen L; Kreiswirth BN; Clancy CJ
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of cefepime on ceftazidime, cefotaxime and imipenem resistant strains of Acinetobacter, Xanthomonas, Pseudomonas, Flavobacterium, Sphingobacterium and on producers of extended spectrum beta-lactamases (ESBL) with resistance transfer].
    Blahová J; Hupková-Lesická M; Králiková K; Krcméry V; Kubonová K
    Cas Lek Cesk; 1997 Mar; 136(5):154-6. PubMed ID: 9221190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of Pseudomonas aeruginosa isolates to ceftazidime is unrelated to the expression of the outer membrane protein OprC.
    Pérez FJ; Navarro D; Gimeno C; García-de-Lomas J
    Chemotherapy; 1997; 43(1):27-30. PubMed ID: 8996738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.